[…] with a comprehensive diagnostics and treatment options for muscular dystrophies including Facioscapulohumeral Muscular Dystrophy ( FSHD). PanRARE connects patients, doctors, academia, key opinion leaders, drug discovery and development enterprises and […]
Genetic testing for FSHD in Asia
Ayurvedic medicine for FSHD – My story
[…] one more time before ‘going public’ with it, or at least run it by an FSHD clinician who practices Western medicine. Today I can confidently say that I’ve met the […]
The FSHD Advocate
The FSHD Advocate Our feature-packed, thrice-a-year magazine can now be enjoyed in digital format. FSHD Advocate‘s purpose is to educate & empower our community to accelerate the developments of treatments. […]
Facio partners with Evotec and initiates FSHD drug discovery program
[…] the identification of compounds showing activity as a potential treatment to stop the progression of FSHD. This agreement marks the start of finding a drug to overcome FSHD. Facio’s drug […]
aTyr Receives U.S. FDA Orphan Designation for FSHD drug
[…] the U.S. Food and Drug Administration (FDA) for the treatment of facioscapulohumeral muscular dystrophy ( FSHD). Resolaris, an investigational new drug representing aTyr’s first Physiocrine-based product candidate in the clinic, is […]